Published in Obesity and Diabetes Week, February 7th, 2005
These results, all of which were generated by Biorex Research and Development Co. prior to CytRx's acquisition of iroxanadine, were included in a poster presentation entitled "The Broad Therapeutic Potential of Pharmaceuticals that Activate Molecular Chaperone Proteins" on January 11, 2005 at the Protein Folding Disorders Conference in San Diego, California.
"The research we are presenting provides...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.